Michael Alaimo, DO
Adult Medicine · Malverne, NYNPI 1659302990
Payments from drug & device makers
Across 570 payments — averaging $31.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Novo Nordisk$3K
- Boehringer Ingelheim$2K
- Sanofi-aventis U.S. LLC$2K
- Amgen$1K
- GSK$1K
- plus $6K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 92 | $3,275 |
| Novo Nordisk | 92 | $2,678 |
| Boehringer Ingelheim | 59 | $2,248 |
| Sanofi-aventis U.S. LLC | 42 | $1,567 |
| Amgen | 37 | $1,297 |
| GSK | 46 | $1,258 |
| Lilly USA, LLC | 44 | $1,180 |
| Merck | 40 | $806 |
| Esperion Therapeutics, Inc. | 10 | $415 |
| Johnson & Johnson | 9 | $346 |
| Cvrx, Inc. | 2 | $345 |
| Pfizer | 17 | $296 |
| AbbVie(2 entities) | 15 | $294 |
| Arbor Pharmaceuticals, Inc. | 15 | $271 |
| Idorsia Pharmaceuticals US Inc | 7 | $251 |
| Xeris Pharmaceuticals, Inc. | 2 | $244 |
| Nevro Corp. | 2 | $185 |
| Novartis | 7 | $146 |
| Teva Pharmaceuticals USA, Inc. | 2 | $127 |
| Intuity Medical Inc | 1 | $125 |
| Amneal Pharmaceuticals LLC | 5 | $121 |
| Currax Pharmaceuticals LLC | 7 | $112 |
| Eisai Inc. | 3 | $71 |
| Amarin Pharma, Inc. | 3 | $57 |
| Kowa Pharmaceuticals America, Inc. | 2 | $54 |
| Exact Sciences | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Bayer | 1 | $25 |
| Corcept Therapeutics | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Alfasigma USA, Inc. | 1 | $18 |
| Medtronic | 1 | $18 |
How this compares
$17,961 in reported general payments places this provider in the 95th percentile of 101 adult medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult medicine in Malverne
- Amir HermanEast Northport$194K
- Vipin OhriWarsaw$14K
- Yuqing ZhangFlushing$13K
- Chidambaranathan ChandrasekaranPatchogue$13K
- Adam CarpentieriMassapequa$11K
- Cary DanielBrooklyn$10K
- Janaki KanumilliMineola$9K
- Zeeshan KhanOceanside$9K
- Thomas MolnarJamaica$8K
- Tehmina NaveedPlainview$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.